Published in Gynakol Geburtshilfliche Rundsch on January 01, 1997
DNA of Mycobacterium tuberculosis in formalin-fixed, paraffin-embedded tissue in tuberculosis and sarcoidosis detected by polymerase chain reaction. Am J Clin Pathol (1994) 2.59
Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol (1997) 1.53
Transfusion-requiring haemolytic anaemia after mitral-valve repair. Lancet (1996) 1.51
Lymphoepithelioma-like carcinoma of the lung. Pathol Res Pract (1995) 1.43
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol (1999) 1.34
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol (2001) 1.33
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet (1999) 1.24
Guidelines on the standards for the training of specialised health professionals dealing with breast cancer. Eur J Cancer (2007) 1.20
Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol (1995) 1.17
Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia: a clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol (1996) 1.04
Sequential treatment of recurrent mesenteric desmoid tumor. Cancer (1996) 1.01
Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med (1988) 1.01
Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol (1999) 1.01
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study. Ann Oncol (2011) 1.00
Hemostatic methods for the management of spleen and liver injuries. World J Surg (1996) 0.98
Spontaneous vaginal delivery in the birth-chair versus in the conventional dorsal position: a matched controlled comparison. Wien Klin Wochenschr (2001) 0.98
Prognostic importance of human papilloma virus typing in squamous cell papilloma of the bronchus: comparison of in situ hybridization and the polymerase chain reaction. Hum Pathol (1994) 0.96
Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol (1998) 0.94
Quality assessment in diagnostic molecular pathology: experience from a German-Austrian-Swiss multicenter trial. Virchows Arch (2000) 0.94
Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood (2000) 0.92
Genomic organization and molecular characterization of a gene encoding HsPXF, a human peroxisomal farnesylated protein. Genomics (1997) 0.92
Vesicocutaneous fistula mimicking an abdominal wall abscess 2 years after radical abdominal hysterectomy. Gynecol Oncol (2003) 0.91
Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study. Int J Gynecol Cancer (2006) 0.91
Partial splenic resection using the TA-stapler. Am J Surg (1994) 0.90
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. Br J Cancer (2011) 0.90
Practice of HER-2 immunohistochemistry in breast carcinoma in Austria. Pathol Oncol Res (2008) 0.90
[Wound rupture after Misgav-Ladach cesarean section: a case report]. Gynakol Geburtshilfliche Rundsch (2004) 0.90
Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost (1998) 0.90
Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res (2001) 0.89
Extranodal follicular dendritic cell tumour of the nasopharynx. Virchows Arch (1998) 0.87
Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer (2001) 0.87
Inguinal lymph node metastasis as the only manifestation of lymphatic spread in ovarian cancer: A case report. Gynecol Oncol (1999) 0.86
Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer. Oncol Rep (2000) 0.86
Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report. Anticancer Res (2006) 0.85
Connatal localized neuroblastoma. The case to delay treatment. Cancer (1996) 0.84
Primary serous papillary carcinoma of the peritoneum: a report of 18 patients. Eur J Gynaecol Oncol (1997) 0.83
Cord blood oxygen saturation in vigorous infants at birth: what is normal? BJOG (2000) 0.82
The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. Gynecol Oncol (1999) 0.82
Photoaccentuated erythroderma associated with CD4+ T lymphocytopenia: successful treatment with 5-methoxypsoralen and UVA, interferon alfa-2b, and extracorporeal photopheresis. J Am Acad Dermatol (1996) 0.82
Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol (1993) 0.81
[On the treatment of prolonged gastrointestinal paralysis]. Dtsch Med J (1969) 0.81
In vitro chemosensitivity testing in the treatment of ovarian carcinoma. Arch Gynecol Obstet (1989) 0.81
[Lymphoepithelioma-like lung carcinomas]. Pathologe (1997) 0.80
Laparoscopic cholecystectomy using 2-mm instruments. J Laparoendosc Adv Surg Tech A (1998) 0.80
[Alpha-ketoglutaric acid increase in the blood and the localization and histology of malignant tumors]. Med Klin (1969) 0.80
Tumor host relations. II. Influence of tumor extent and tumor site on plasma cortisol of patients with malignant diseases. J Cancer Res Clin Oncol (1979) 0.80
Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer. Cancer Chemother Pharmacol (1991) 0.80
[New organ-preserving technics for third-grade splenic trauma. An experimental study]. Z Exp Chir Transplant Kunstliche Organe (1990) 0.80
Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass. Anticancer Res (2001) 0.79
Do primiparas aged 40 years or older carry an increased obstetric risk? Prev Med (1999) 0.79
Laparoscopic partial splenic resection. Surg Laparosc Endosc (1995) 0.79
[Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer]. Dtsch Med Wochenschr (1987) 0.79
[Change in the concentration of alpha-ketoglutaric acid in carcinoma patients by potassium-magnessium aspartate. 2]. Med Klin (1968) 0.79
On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations. Wien Klin Wochenschr (1986) 0.79
Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay. Am J Obstet Gynecol (1991) 0.79
Feasible model for locoregional and systemic longterm administration of drugs and concomitant blood sampling in Sprague-Dawley rats. J Cancer Res Clin Oncol (1987) 0.78
Angiotropic large cell lymphoma presenting as thrombotic microangiopathy (thrombotic thrombocytopenic purpura). Cancer (1995) 0.78
[Alpha-ketoglutaric acid in the blood in benign diseases]. Med Klin (1969) 0.78
Tumor host relations. I. Increased plasma cortisol in tumor-bearing humans compared with patients with benign surgical diseases. J Cancer Res Clin Oncol (1979) 0.78
[Miliary tuberculosis of the liver as a cause of septic shock with multi-organ failure]. Wien Klin Wochenschr (1994) 0.78
[Pyruvic acid, lactic acid and alpha-ketoglutaric acid in carcinoma patients. 1]. Med Klin (1968) 0.78
[A twenty year-review of the surgery of peptic ulcers at the clinic Spath in Graz]. Langenbecks Arch Chir (1969) 0.78
Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line. Gynecol Oncol (1990) 0.77
Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancer. Breast Cancer Res Treat (2000) 0.77
Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group. J Cancer Res Clin Oncol (2008) 0.77
Immunological surrogate parameters in a prognostic model for multi-organ failure and death. Eur J Med Res (2000) 0.77
Infantile sialic acid storage disease: the fate of biosynthetically labeled N-acetyl-(3H)-neuraminic acid in cultured human fibroblasts. Pediatr Res (1986) 0.77
Sigmoid model versus median-effect analysis for obtaining dose-response curves for in vitro chemosensitivity testing. Int J Clin Pharmacol Ther (1999) 0.77
A novel type of mutation at the propeptide cleavage site (AlA+1Thr) causing symptomatic protein C type II deficiency. Thromb Res (2000) 0.76
[Effective intraluminal concentration of riboflavin and pyridoxine in various intestinal segments of the rat]. Z Ernahrungswiss (1984) 0.76
Consolidation radiotherapy following carboplatin-based chemotherapy in radically operated advanced ovarian cancer. A pilot study. Am J Clin Oncol (1991) 0.76
Bone marrow lymphocyte subsets in myelodysplastic syndromes. J Clin Pathol (1994) 0.76
Therapeutic ratio of mono or combination bacterial lipopolysaccharide therapy in methylnitrosourea-induced rat mammary carcinoma. J Cancer Res Clin Oncol (1987) 0.76
Possible influence of granulocyte colony-stimulating factor and recombinant human erythropoietin on human chorionic gonadotropin secretion during chemotherapy for choriocarcinoma. Gynecol Oncol (2001) 0.76
[On the prevention of thrombosis with aesculus extract]. Med Klin (1969) 0.76
Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis. J Invest Dermatol (2001) 0.75
Stage IV ovarian cancer: prognostic factors and survival beyond 5 years. Anticancer Res (2002) 0.75
Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study. Anticancer Res (2001) 0.75
[Is the search for Meckel's diverticulum in appendectomy still a current problem in common surgical practice?]. Chirurg (1989) 0.75
Bone marrow granulomas in hairy cell leukaemia. Histopathology (1996) 0.75
Re: intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. Gynecol Oncol (2006) 0.75
Re: "Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy". Gynecol Oncol (2005) 0.75
Influence of perinatal nicotine administration on transplacental carcinogenesis in Sprague Dawley rats by N-methylnitrosourea. Br J Cancer (1987) 0.75
Metabolism of debrisoquine and susceptibility to breast cancer. Breast Cancer Res Treat (1991) 0.75
[Intraduodenal pH value and the emptying of the stomach]. Klin Med Osterr Z Wiss Prakt Med (1967) 0.75
What's in a title - Mr or Dr? J R Soc Med (1994) 0.75
Spontaneous small bowel perforation. A rare cause of acute abdomen. Acta Chir Scand (1990) 0.75
[Experiences with the surgical therapy of esophagus-carcinoma]. Langenbecks Arch Chir (1969) 0.75
[Clinical use of new organ-saving technics in splenic surgery]. Chirurg (1990) 0.75
[Serum cholinesterase activity in stomach carcinoma]. Osterr Z Erforsch Bekampf Krebskr (1970) 0.75
[Difficult closure of the duodenal stump]. Chirurg (1987) 0.75
The technique of the low anterior resection made by hand or with stapler. Mater Med Pol (1993) 0.75
[On the effect of the female sex hormone on ulcer of the upper digestive tract]. Endokrinologie (1966) 0.75
TA-stapler resection of congenital splenic cyst. Case report. Acta Chir Scand (1990) 0.75
[Experiences in the surgical treatment of lung tumors]. Thoraxchir Vask Chir (1970) 0.75
[Emergency interventions in perforation of gastroduodenal ulcer]. Chirurg (1986) 0.75
[Splenic cyst--a rare cause of epigastric expansion]. Langenbecks Arch Chir (1990) 0.75
[On the substitution of HCl deficiency in the stomach with organic aicds]. Dtsch Med J (1967) 0.75